|
Volumn 24, Issue 3, 2008, Pages 129-132
|
The World Health Organization defines hormone replacement therapy as carcinogenic: Is this plausible?
|
Author keywords
Carcinogen; Estrogen; Hormone replacement therapy; Menopause; Progestogen
|
Indexed keywords
4 HYDROXYESTROGEN DERIVATIVE;
ACETYLSALICYLIC ACID;
ASBESTOS;
ASCORBIC ACID;
BENZO[A]PYRENE;
CARCINOGEN;
CONTRACEPTIVE AGENT;
ESTRADIOL;
ESTROGEN;
ESTROGEN DERIVATIVE;
GESTAGEN;
PROGESTERONE;
TAMOXIFEN;
TOBACCO SMOKE;
UNCLASSIFIED DRUG;
BREAST CANCER;
BREAST CARCINOMA;
CANCER HORMONE THERAPY;
CANCER RISK;
CARCINOMA IN SITU;
CHEMICAL CARCINOGENESIS;
CHROMOSOME ABERRATION;
CLINICAL PRACTICE;
COLORECTAL CANCER;
DRUG SAFETY;
ENDOMETRIUM CANCER;
ENVIRONMENTAL FACTOR;
ESTROGEN METABOLISM;
ESTROGEN THERAPY;
EXPERIMENTAL MODEL;
HORMONAL CONTRACEPTION;
HORMONE SUBSTITUTION;
HUMAN;
INVASIVE CARCINOMA;
KIDNEY TUMOR;
LOW DRUG DOSE;
MALIGNANT TRANSFORMATION;
MENOPAUSE;
MONOTHERAPY;
NONHUMAN;
NUTRITION;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
REVIEW;
RISK ASSESSMENT;
RISK REDUCTION;
SIDE EFFECT;
TUMOR PROMOTION;
WORLD HEALTH ORGANIZATION;
BREAST NEOPLASMS;
CARCINOGENS;
ENDOMETRIAL NEOPLASMS;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HUMANS;
MENOPAUSE;
NEOPLASMS;
PROGESTINS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK FACTORS;
WOMEN'S HEALTH;
WORLD HEALTH ORGANIZATION;
|
EID: 40549125609
PISSN: 09513590
EISSN: 14730766
Source Type: Journal
DOI: 10.1080/09513590801893349 Document Type: Review |
Times cited : (9)
|
References (36)
|